中药治疗肝癌研究现状.pdfVIP

传染病信息 2012 年 6 月 30 日 第25 卷 第 3 期 Infect Dis Info, Vol. 25, No. 3, June 30, 2012 189 · · subcontinent ［］ Hepatology, 2009, 51(4):647-654. J . Intervirology, 2012, 55(1):36-44. [12] Arrese E, Basaras M, Blanco S, et al. Evolution of hepatitis B virus [20] Mirandola S, Campagnolo D, Bortoletto G, et al. Large-scale sur－ ［］ during long-term therapy in patients with chronic hepatitis B J . vey of naturally occurring HBV polymerase mutations associated Ann Hepatol, 2011, 10(4):434-440. with anti-HBV drug resistance in untreated patients with chronic ［］ [13] Sayan M, Sentürk O, Akhan SC, et al. Monitoring of hepatitis B hepatitis B J . J Viral Hepat, 2011, 18(7):e212-e216. virus surface antigen escape mutations and concomitantly nucleos- [21] Curtis M, Zhu Y, Borroto-Esoda K. Hepatitis B virus containing (t)ide analog resistance mutations in Turkish patients with chronic the I233V mutation in the polymerase reverse -transcriptase do - hepatitis B ［］ main remains sensitive to inhibition by adefovir ［］ J . Int J Infect Dis, 2010, 14(Suppl 3):S136-S141. J . J Infect Dis, [14] Westland CE, Yang H, Delaney WE 4th, et al. Week 48 resistance 2007, 196(10):1483-1486. surveillance in two phase 3 clin